Science
Mechanism of Action
This hexapeptide functions as an antagonist of PGC-1α (Peroxisome proliferator-activated receptor-gamma coactivator 1α), a crucial molecular switch regulating adipocyte differentiation and maturation. By downregulating PGC-1α expression, HEXAPEPTIDE-39 effectively hinders the maturation rate of preadipocytes and diminishes lipid accumulation within adipose tissue. This action translates to a reduction in the thickness and waviness of the dermo-hypodermal junction, thereby mitigating the visual characteristics of cellulite and promoting enhanced skin uniformity without directly burning fat.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
Data not available to determine dusting profile for this specific ingredient.
The Formula
Formulation
Stability
For optimal stability, HEXAPEPTIDE-39 should be incorporated into formulations at the final stage, ensuring temperatures remain below 45 °C. It exhibits robust stability and compatibility across a range of applications, including gels, emulsions, and targeted slimming treatments.
Safety
Safety Profile
Specific safety assessments from major regulatory bodies such as CIR, SCCS, or FDA for HEXAPEPTIDE-39 (Silusyne) are currently unavailable. While related peptides like Acetyl Hexapeptide-8 Amide have been deemed safe by CIR at concentrations up to 0.005%, it is important to note that HEXAPEPTIDE-39 is a distinct molecular entity and requires its own specific evaluation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
HEXAPEPTIDE-39 is a valuable ingredient for precision body contouring and smoothing skin irregularities, particularly in reducing the appearance of cellulite, despite awaiting comprehensive regulatory safety review.
Related
Similar Ingredients
Finding similar ingredients…